# Olanzapine Compared to Lamotrigine in the Prevention of Depressive Episode in the Patients With Bipolar Disorder

> **NCT01864551** · PHASE4 · COMPLETED · sponsor: **Tri-Service General Hospital** · enrollment: 60 (actual)

## Conditions studied

- Bipolar Disorder

## Interventions

- **DRUG:** Lamotrigine
- **DRUG:** Olanzapine

## Key facts

- **NCT ID:** NCT01864551
- **Lead sponsor:** Tri-Service General Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-08
- **Primary completion:** 2009-07
- **Final completion:** 2012-09
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2013-05-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01864551

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01864551, "Olanzapine Compared to Lamotrigine in the Prevention of Depressive Episode in the Patients With Bipolar Disorder". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT01864551. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*